Works by Lin, Han‐Chieh


Results: 152
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    East Asia expert opinion on treatment initiation for chronic hepatitis B.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 10, p. 1540, doi. 10.1111/apt.16097
    By:
    • Kao, Jia‐Horng;
    • Hu, Tsung‐Hui;
    • Jia, Jidong;
    • Kurosaki, Masayuki;
    • Lim, Young‐Suk;
    • Lin, Han‐Chieh;
    • Sinn, Dong Hyun;
    • Tanaka, Yasuhito;
    • Wai‐Sun Wong, Vincent;
    • Yuen, Man‐Fung
    Publication type:
    Article
    15

    Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action. Authors' reply.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1430, doi. 10.1111/apt.15718
    By:
    • Estes, Chris;
    • Chan, Henry L. Y.;
    • Chien, Rong N.;
    • Chuang, Wan‐Long;
    • Fung, James;
    • Goh, George Boon‐Bee;
    • Hu, Tsung H.;
    • Huang, Jee‐Fu;
    • Jang, Byoung K.;
    • Jun, Dae W.;
    • Kao, Jia H.;
    • Lee, Jin‐Woo;
    • Lin, Han‐Chieh;
    • Razavi‐Shearer, Kathryn;
    • Seto, Wai‐Kay;
    • Wong, Grace L.‐H.;
    • Wong, Vincent W.‐S.;
    • Razavi, Homie
    Publication type:
    Article
    16

    Modelling NAFLD disease burden in four Asian regions—2019‐2030.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 8, p. 801, doi. 10.1111/apt.15673
    By:
    • Estes, Chris;
    • Chan, Henry L. Y.;
    • Chien, Rong N.;
    • Chuang, Wan‐Long;
    • Fung, James;
    • Goh, George Boon-Bee;
    • Hu, Tsung H.;
    • Huang, Jee‐Fu;
    • Jang, Byoung K.;
    • Jun, Dae W.;
    • Kao, Jia H.;
    • Lee, Jin‐Woo;
    • Lin, Han‐Chieh;
    • Razavi‐Shearer, Kathryn;
    • Seto, Wai‐Kay;
    • Wong, Grace L. ‐H.;
    • Wong, Vincent W. ‐S.;
    • Razavi, Homie
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Serum adrenomedullin and urinary thromboxane B<sub>2</sub> help early categorizing of acute kidney injury in decompensated cirrhotic patients: A prospective cohort study.

    Published in:
    Hepatology Research, 2018, v. 48, n. 3, p. E9, doi. 10.1111/hepr.12917
    By:
    • Liu, Chih‐wei;
    • Huang, Chia‐chang;
    • Tsai, Hung‐cheng;
    • Su, Yen‐bo;
    • Huang, Shiang‐fen;
    • Lee, Kuei‐chuan;
    • Hsieh, Yun‐cheng;
    • Li, Tzu‐hao;
    • Tsai, Chang‐youh;
    • Chong, Lee‐won;
    • Ou, Shuo‐ming;
    • Yang, Ying‐ying;
    • Fan, Wen‐chien;
    • Hou, Ming‐chih;
    • Lin, Han‐chieh;
    • Lee, Shou‐dong
    Publication type:
    Article
    33
    34
    35
    36
    37

    Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice.

    Published in:
    BioMed Research International, 2019, p. 1, doi. 10.1155/2019/6740616
    By:
    • Tsai, Hung-Cheng;
    • Chang, Fu-Pang;
    • Li, Tzu-Hao;
    • Liu, Chih-Wei;
    • Huang, Chia-Chang;
    • Huang, Shiang-Fen;
    • Yang, Ying-Ying;
    • Lee, Kuei-Chuan;
    • Hsieh, Yun-Cheng;
    • Wang, Ying-Wen;
    • Lee, Tzung-Yan;
    • Huang, Yi-Hsiang;
    • Hou, Ming-Chih;
    • Lin, Han-Chieh
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50